GlassScriptPhysician profile
Shane M Gjesdal
NPI 1164424586
$8,303.77
in general payments reported to CMS, 2019-2025
33 companies · $653 in 2025
The $653 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $405 · 2021: $476 · 2022: $5,408 · 2023: $529 · 2024: $447 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,466 · Education: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.89 |
| Education | $162.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,034.63 | 2022 | |
| Astellas Pharma US INC | $487.57 | 2021-2025 | Veozah, Myrbetriq |
| Daiichi Sankyo INC. | $396.44 | 2019-2025 | Injectafer |
| Abbvie INC. | $368.77 | 2019-2023 | |
| Hologic Sales and Service, LLC | $224.30 | 2019-2025 | Acessa Provu System |
| Merck Sharp & Dohme LLC | $189.18 | 2019-2025 | Gardasil 9 |
| Pfizer INC. | $173.45 | 2019-2025 | |
| Therapeuticsmd, INC. | $170.80 | 2020-2021 | |
| Organon LLC | $160.18 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $131.75 | 2025 | Slynd |
| Davol INC. | $122.28 | 2023-2025 | Arista Ah Flexitip, Arista |
| Bayer Healthcare Pharmaceuticals INC. | $119.31 | 2019-2020 | |
| Baxter Healthcare | $80.25 | 2022-2024 | Perclot, Adept |
| Coopersurgical, INC. | $77.97 | 2019-2025 | Endosee |
| Ethicon US, LLC | $69.10 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $55.04 | 2019-2025 | Bd Onclarity |
| Vertex Pharmaceuticals Incorporated | $53.46 | 2025 | |
| Myovant Sciences INC. | $51.60 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $49.11 | 2024-2025 | Myfembree |
| Teleflex LLC | $41.70 | 2025 | Quikclot, Weck |
| Biohaven Pharmaceutical Holding Company LTD. | $28.23 | 2022 | |
| Evofem Biosciences, INC. | $23.59 | 2022 | |
| Kyowa Kirin, INC. | $22.63 | 2024 | Crysvita |
| Biogen, INC. | $21.39 | 2025 | Zurzuvae |
| Smith+Nephew, INC. | $21.22 | 2021 | |
| Amag Pharmaceuticals, INC. | $19.78 | 2019 | |
| Novo Nordisk INC | $19.53 | 2024 | Wegovy |
| Alexion Pharmaceuticals, INC. | $18.00 | 2025 | Ultomiris |
| Microline Surgical INC | $17.13 | 2024 | |
| Minerva Surgical, INC | $15.78 | 2023 | |
| Medtronic, INC. | $14.85 | 2022 | |
| Boston Scientific Corporation | $13.58 | 2023 | Spaceoar Vue System - 10ml |
| Dysis Medical, INC. | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Gjesdal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.